Comparing recovery methods after laparoscopic sleeve gastrectomy
Quality of Recovery in Laparoscopic Sleeve Gastrectomy Using Dexmedetomidine Infusion Versus Laparoscopic TAP Block in Combination With Paragastric Neural Block
PHASE2; PHASE3 · Alexandria University · NCT06970626
This study is testing which recovery method works better for people with obesity after laparoscopic sleeve gastrectomy by comparing two different pain management techniques.
Quick facts
| Phase | PHASE2; PHASE3 |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 20 Years to 60 Years |
| Sex | All |
| Sponsor | Alexandria University (other) |
| Locations | 1 site (Alexandria) |
| Trial ID | NCT06970626 on ClinicalTrials.gov |
What this trial studies
This clinical trial aims to determine which recovery method is more effective for patients undergoing laparoscopic sleeve gastrectomy: a combination of dexmedetomidine infusion and paragastric neural block or a combination of laparoscopic TAP block and paragastric neural block. The study will evaluate recovery by measuring opioid consumption, hemodynamic stability, pain scores, quality of postoperative recovery, and incidence of nausea or vomiting. It involves patients with a BMI of 35-50 kg/m2 and ASA physical status II-III, assessing their recovery outcomes post-surgery.
Who should consider this trial
Good fit: Ideal candidates for this study are patients with a BMI between 35 and 50 kg/m2 and classified as ASA physical status II-III.
Not a fit: Patients with significant hepatic, renal, neuromuscular, or cardiac impairments, extreme obesity (BMI > 50 kg/m2), or those currently on opioid medication may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved recovery protocols for patients undergoing laparoscopic sleeve gastrectomy, potentially reducing pain and opioid use.
How similar studies have performed: Other studies have shown promising results with similar approaches in enhancing recovery after surgical procedures, suggesting potential for success in this trial.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. American Society of Anesthesiologists (ASA) physical status II- III 2. BMI 35- 50 kg/m2 Exclusion Criteria: 1. Significant hepatic, renal, neuromuscular, or cardiac impairments 2. Extreme obesity (BMI \> 50 kg/m2) 3. Patients on current opioid medication 4. Allergies to dexmedetomidine or bupivacaine
Where this trial is running
Alexandria
- Alexandria Main University Hospital — Alexandria, Egypt (RECRUITING)
Study contacts
- Study coordinator: Mai A El-Sayed, Lecturer of Anesthesia
- Email: m_mohamed165@alexmed.edu.eg
- Phone: 00201287459922
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Laparoscopic Sleeve Gastrectomy, dexmedetomidine, Paragastric Neural Block, Laparoscopic TAP